Patents by Inventor David Eveleth

David Eveleth has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • RECOMBINANT MODIFIED FIBROBLAST GROWTH FACTORS AND THERAPEUTIC USES THEREOF
    Publication number: 20240024421
    Abstract: Described herein are suitable formulations of modified fibroblast growth factor (FGF) and methods of making, for delivery in the eye, polypeptides, pharmaceutical compositions and medicaments that include such modified FGF polypeptides, and methods of using such modified FGF polypeptides to treat or prevent conditions that benefit from administration of FGFs.
    Type: Application
    Filed: December 21, 2022
    Publication date: January 25, 2024
    Inventor: David Eveleth
  • RECOMBINANT MODIFIED FIBROBLAST GROWTH FACTORS AND THERAPEUTIC USES THEREOF
    Publication number: 20230130851
    Abstract: Described herein are modified fibroblast growth factor (FGF) polypeptides, pharmaceutical compositions and medicaments that include such modified FGF polypeptides, and methods of using such modified FGF polypeptides to treat or prevent conditions that benefit from administration of FGFs.
    Type: Application
    Filed: September 7, 2022
    Publication date: April 27, 2023
    Inventors: David EVELETH, Jennifer JENKINS-EVELETH, Amuthakannan SUBRAMANIAM, Ralph BRADSHAW
  • Recombinant modified fibroblast growth factors and therapeutic uses thereof
    Patent number: 11479591
    Abstract: Described herein are modified fibroblast growth factor (FGF) polypeptides, pharmaceutical compositions and medicaments that include such modified FGF polypeptides, and methods of using such modified FGF polypeptides to treat or prevent conditions that benefit from administration of FGFs.
    Type: Grant
    Filed: May 4, 2018
    Date of Patent: October 25, 2022
    Assignee: TREFOIL THERAPEUTICS, INC.
    Inventors: David Eveleth, Jennifer Jenkins-Eveleth, Amuthakannan Subramaniam, Ralph Bradshaw
  • MODIFIED FIBROBLAST GROWTH FACTORS FOR THE TREATMENT OF OCULAR DISORDERS
    Publication number: 20210338777
    Abstract: Described herein are modified fibroblast growth factors (FGFs), pharmaceutical compositions, ophthalmic formulations, and medicaments that include such modified FGFs, and methods of using such modified FGFs to treat ocular diseases, disorders, or conditions.
    Type: Application
    Filed: July 16, 2021
    Publication date: November 4, 2021
    Inventors: David EVELETH, Kenneth A. THOMAS
  • Modified fibroblast growth factors for the treatment of ocular disorders
    Patent number: 11103553
    Abstract: Described herein are modified fibroblast growth factors (FGFs), pharmaceutical compositions, ophthalmic formulations, and medicaments that include such modified FGFs, and methods of using such modified FGFs to treat ocular diseases, disorders, or conditions.
    Type: Grant
    Filed: September 24, 2014
    Date of Patent: August 31, 2021
    Assignee: TREFOIL THERAPEUTICS, INC.
    Inventors: David Eveleth, Kenneth A. Thomas, Jr.
  • MODIFIED FIBROBLAST GROWTH FACTORS AND USES THEREOF
    Publication number: 20210009650
    Abstract: Described herein are modified fibroblast growth factors (FGFs), pharmaceutical compositions, formulations, and medicaments that include such modified FGFs, and methods of using such modified FGFs to treat mammalian diseases, disorders, or conditions.
    Type: Application
    Filed: March 24, 2017
    Publication date: January 14, 2021
    Inventors: David EVELETH, Ralph A. BRADSHAW
  • RECOMBINANT MODIFIED FIBROBLAST GROWTH FACTORS AND THERAPEUTIC USES THEREOF
    Publication number: 20200190158
    Abstract: Described herein are modified fibroblast growth factor (FGF) polypeptides, pharmaceutical compositions and medicaments that include such modified FGF polypeptides, and methods of using such modified FGF polypeptides to treat or prevent conditions that benefit from administration of FGFs.
    Type: Application
    Filed: May 4, 2018
    Publication date: June 18, 2020
    Inventors: David EVELETH, Jennifer JENKINS-EVELETH, Amuthakannan SUBRAMANIAM, Ralph BRADSHAW
  • Treatment of autoimmune and/or inflammatory disease using novel caveolin modulators
    Patent number: 10537607
    Abstract: Provided herein are novel compositions, specifically, caveolin modulators, and methods to treat and/or prevent autoimmune and/or inflammatory diseases/conditions using such compositions.
    Type: Grant
    Filed: November 21, 2014
    Date of Patent: January 21, 2020
    Assignee: E&B Technologies LLC
    Inventors: David Eveleth, William C. Sessa
  • TREATMENT OF AUTOIMMUNE AND/OR INFLAMMATORY DISEASE USING NOVEL CAVEOLIN MODULATORS
    Publication number: 20170128520
    Abstract: Provided herein are novel compositions, specifically, caveolin modulators, and methods to treat and/or prevent autoimmune and/or inflammatory diseases/conditions using such compositions.
    Type: Application
    Filed: November 21, 2014
    Publication date: May 11, 2017
    Applicant: E&B TECHNOLOGIES LLC
    Inventors: David EVELETH, William C. SESSA
  • MODIFIED FIBROBLAST GROWTH FACTORS FOR THE TREATMENT OF OCULAR DISORDERS
    Publication number: 20160263190
    Abstract: Described herein are modified fibroblast growth factors (FGFs), pharmaceutical compositions, ophthalmic formulations, and medicaments that include such modified FGFs, and methods of using such modified FGFs to treat ocular diseases, disorders, or conditions.
    Type: Application
    Filed: September 24, 2014
    Publication date: September 15, 2016
    Inventors: David EVELETH, Kenneth A. THOMAS, Jr.
  • Method of using cox-2 inhibitors in the treatment and prevention of ocular cox-2 mediated disorders
    Publication number: 20040058926
    Abstract: The present invention provides methods for the treatment and prevention of ocular COX-2 mediated disorders using COX-2 inhibitors.
    Type: Application
    Filed: September 22, 2003
    Publication date: March 25, 2004
    Inventors: Rebanta Bandyopadhyay, David Eveleth, Tom Van Haarlem, Tugrul T Kararli, Satish K. Singh
  • Method of using COX-2 inhibitors in the treatment and prevention of ocular COX-2 mediated disorders
    Publication number: 20020128267
    Abstract: The present invention provides methods for the treatment and prevention of ocular COX-2 mediated disorders using COX-2 inhibitors.
    Type: Application
    Filed: May 4, 2001
    Publication date: September 12, 2002
    Inventors: Rebanta Bandyopadhyay, David Eveleth, Thomas Joseph Van Haarlem, Tugrul T. Kararli, Satish K. Singh